Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide

We describe here the case of an elderly female with severe osteoporosis, who presented with a worsening backache, following teriparatide treatment. She was subsequently diagnosed to have normocalcemic primary hyperparathyroidism. Before prescribing teriparatide, an appropriate endocrine evaluation m...

Full description

Bibliographic Details
Main Author: Vishal Gupta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=2;spage=336;epage=338;aulast=Gupta
_version_ 1818290243260907520
author Vishal Gupta
author_facet Vishal Gupta
author_sort Vishal Gupta
collection DOAJ
description We describe here the case of an elderly female with severe osteoporosis, who presented with a worsening backache, following teriparatide treatment. She was subsequently diagnosed to have normocalcemic primary hyperparathyroidism. Before prescribing teriparatide, an appropriate endocrine evaluation must be undertaken by all healthcare physicians (serum intact parathyroid hormone (iPTH) level), despite having a normal serum calcium. Normocalcemic hyperparathyroidism should be considered as an important alternate cause for osteoporosis.
first_indexed 2024-12-13T02:25:04Z
format Article
id doaj.art-4ba56d8c572e4c32b9786f235cf80c4a
institution Directory Open Access Journal
issn 2230-8210
2230-9500
language English
last_indexed 2024-12-13T02:25:04Z
publishDate 2013-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Endocrinology and Metabolism
spelling doaj.art-4ba56d8c572e4c32b9786f235cf80c4a2022-12-22T00:02:40ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102230-95002013-01-0117233633810.4103/2230-8210.109664Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatideVishal GuptaWe describe here the case of an elderly female with severe osteoporosis, who presented with a worsening backache, following teriparatide treatment. She was subsequently diagnosed to have normocalcemic primary hyperparathyroidism. Before prescribing teriparatide, an appropriate endocrine evaluation must be undertaken by all healthcare physicians (serum intact parathyroid hormone (iPTH) level), despite having a normal serum calcium. Normocalcemic hyperparathyroidism should be considered as an important alternate cause for osteoporosis.http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=2;spage=336;epage=338;aulast=GuptaForsteohyperparathyroidismnormocalcemic hyperparathyroidismosteoporosisparathyroid adenomateriparatide
spellingShingle Vishal Gupta
Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
Indian Journal of Endocrinology and Metabolism
Forsteo
hyperparathyroidism
normocalcemic hyperparathyroidism
osteoporosis
parathyroid adenoma
teriparatide
title Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
title_full Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
title_fullStr Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
title_full_unstemmed Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
title_short Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
title_sort normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
topic Forsteo
hyperparathyroidism
normocalcemic hyperparathyroidism
osteoporosis
parathyroid adenoma
teriparatide
url http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=2;spage=336;epage=338;aulast=Gupta
work_keys_str_mv AT vishalgupta normocalcemicprimaryhyperparathyroidisminapatientwithsevereosteoporosisreceivingteriparatide